US Stock MarketDetailed Quotes

CUTR Cutera

Watchlist

0.467
-0.023-4.69%

Close Jan 22 16:00 ET

0.492
+0.025+5.35%

Post 20:01 ET

9.43MMarket Cap-0.07P/E (TTM)

Cutera Stock Forum

TranceHead

Jan 7 15:39

damn

$Cutera (CUTR.US)$ should have sold at .7 and possibly re-entered

Jaguar8

Jan 6 11:54

Probably an upcoming PR with it previous partnership with L’oreal in Japan

$Cutera (CUTR.US)$ 👀

🔶December 2024 Upcoming Catalysts. Save it. In alphabetical order

$ABVC BioPharma (ABVC.US)$ - Progress continues in our ADHD program with Phase IIb trials at multiple prominent sites. We aim to have an interim report by Q4 2024. ABV-1601 for MDD in cancer patients has completed Phase I study preparation, including the Site Initiation Visit (SIV). The study is set to initiate by the end of 2024.
$Ascent Solar Technologies (ASTI.US)$- Following delivery and the successful completion of the on-orbi...

trailerparkolympics

Dec 6, 2024 06:47

$Cutera (CUTR.US)$ I'll buy

Johnny Mnemonic

Jul 5, 2024 09:21

turnover is finally starting to turn around, under 20m, float s over 30%, change - up

$Cutera (CUTR.US)$
businesswire.co...

amiable Hedgehog_758

May 7, 2024 13:36

$Cutera (CUTR.US)$
March 21, 2024 04:01 PM Eastern Daylight Time
BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today reported financial results for the fourth quarter and full-year ended December 31, 2023.
“We are now squarely focused on our most important priorities, which are operational excellence and building a successful AviClear franchise across the globe.”
Post this
• Consolidated reve...